AGL - NYSE
Agilon Health, Inc.
$97.68
+18%agilon health, inc. offers healthcare services for seniors through primary care physicians in the communities of the United States. As of December 31, 2021, it served approximately 238,000 senior members, which included 186,300 medicare advantage members and 51,700 medicare fee-for-service beneficiaries. The company was formerly known as Agilon Health Topco, Inc. and changed its name to agilon health, inc. in March 2021. agilon health, inc. was founded in 2016 and is based in Austin, Texas.
At a Glance
Live SnapshotAgilon Health, Inc. Cash Conversion Engine
Cash Flow Quality Analysis
FCF Conversion Rate
Weak cash conversion. Significant portion of earnings not converting to cash—review working capital trends and capital intensity.
CapEx Intensity
Asset-light business model. Low capital requirements leave more cash available for shareholders and growth investments.
FCF Growth Trend
Significant FCF decline raises concerns. Urgent review needed of operational performance and capital allocation.
Working Capital Impact
Working capital inflow boosted cash flow. Efficient management of receivables, inventory, and payables contributing positively.
Cash Flow Quality Insight
Deteriorating cash generation: Both declining FCF and weak conversion rate signal fundamental challenges. Investigate margin pressure, rising costs, or working capital issues.
Agilon Health, Inc. Cash Flow Statement
AGL • NYSE
| Agilon Health, Inc. Cash Flow Statement | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 |
|---|---|---|---|---|---|---|---|
OPERATING ACTIVITIES | |||||||
-391.3M | -260.1M | -262.8M | -106.9M | -406.8M | -60.1M | -282.7M | |
28.6M | 24.5M | 20.2M | 13.8M | 14.7M | 14.1M | 41.4M | |
0.0 | 0.0 | 0.0 | 532K | -3.2M | -2.8M | -16.2M | |
49.1M | 50.7M | 69.3M | 28.4M | 292.4M | 6.7M | 5.2M | |
18.4M | -3.4M | 27.2M | -7.2M | 9.8M | -17.6M | 115.2M | |
(0.0) | (1.8M) | (5.4M) | (5.3M) | (1.8M) | (2K) | (0.0) | |
189.5M | 130.6M | -10.1M | -59.4M | -55M | 6.5M | 33.2M | |
-105.8M | -57.8M | -156.2M | -130.8M | -148.2M | -53.2M | -103.9M | |
INVESTING ACTIVITIES | |||||||
-13.2M | -13.3M | -15.8M | -15.4M | -13.4M | -2.4M | -3.9M | |
(0.0) | (0.0) | -43.1M | (500K) | -1.3M | (26.2M) | (0.0) | |
-60.2M | -12M | -114.7M | -458.3M | -7.1M | -2.1M | (0.0) | |
193.9M | 206.9M | 164M | 52.5M | 7.1M | 2.1M | 0.0 | |
-31.9M | -41.8M | -34.5M | -23.7M | -75.7M | -1.8M | -1.2M | |
(88.6M) | (139.9M) | -44M | -444.4M | -90.5M | (22.1M) | -5.1M | |
FINANCING ACTIVITIES | |||||||
-3M | 1.2M | -188.1M | 33.1M | 1.2B | 27.7M | 180.2M | |
0.0 | -3.8M | -5M | -5M | -19.9M | -3M | -3.6M | |
-3M | (0.0) | -200M | (0.0) | (0.0) | -6.7M | (0.0) | |
0.0 | 0.0 | 11.9M | 0.0 | -14.7M | 0.0 | -303K | |
-3M | -2.6M | -193.1M | 28.1M | 1.2B | 24.6M | 176.3M | |
CASH FLOW SUMMARY | |||||||
-20.1M | 79.5M | -393.4M | -547.1M | 915.7M | -6.5M | 67.4M | |
193.9M | 114.3M | 507.7M | 1.1B | 139.1M | 145.6M | 78.2M | |
173.7M | 193.9M | 114.3M | 507.7M | 1.1B | 139.1M | 145.6M | |
-119M | -71M | -187M | -163.5M | -161.6M | -55.6M | -107.8M |
SEC Filings
AGL - Filing history and reports
| Filing Type | Filing Date | Period Ending | Fiscal Year | Actions |
|---|---|---|---|---|
8-K 8-K 2026 N/A | June 03, 2026 | June 02, 2026 | 2026 | |
10-Q 10-Q 2026 Q1 Q1 | May 06, 2026 | March 31, 2026 | 2026 | |
8-K 8-K 2026 N/A | May 06, 2026 | May 06, 2026 | 2026 | |
8-K 8-K 2026 N/A | April 27, 2026 | April 24, 2026 | 2026 | |
DEF 14A DEF 14A 2026 N/A | April 22, 2026 | June 02, 2026 | 2026 | |
8-K 8-K 2026 N/A | March 30, 2026 | March 30, 2026 | 2026 | |
8-K 8-K 2026 N/A | March 18, 2026 | March 17, 2026 | 2026 | |
10-K 10-K 2025 FY FY | February 25, 2026 | December 31, 2025 | 2025 | |
8-K 8-K 2026 N/A | February 25, 2026 | February 25, 2026 | 2026 | |
DEF 14A DEF 14A 2026 N/A | February 18, 2026 | March 17, 2026 | 2026 |
Related Guides
Continue your AGL research with focused valuation guides.
Research Paths
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.